Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
This study has been terminated.
( This study was prematurely terminated (26 June 2009) due to slow recruitment )
Study NCT00352768   Information provided by Solvay Pharmaceuticals
First Received: July 14, 2006   Last Updated: September 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive Compulsive Disorder
Additional conditions recognized in this trial
Disease
Obsessive-Compulsive Disorder
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Fluvoxamine Maleate
Placebo
Additional drug interventions recognized in this trial
Fluvoxamine
Maleic acid
More general drug interventions related to this trial
Anti-Anxiety Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Solvay Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services